Hc Advisors, LLC Cytokinetics Inc Transaction History

Hc Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$63.75 - $108.06 $10,200 - $17,289	-160 Reduced 4.93%	3,083 $216,000
Q4 2023 Jan 25, 2024	BUY	$26.88 - $83.49 $87,171 - $270,758	3,243 New	3,243 $270,000
Q2 2021 Aug 09, 2021	SELL	$19.79 - $26.99 $178,288 - $243,152	-9,009 Closed	0 $0
Q1 2021 May 07, 2021	SELL	$18.57 - $25.68 $384,083 - $531,139	-20,683 Reduced 69.66%	9,009 $210,000
Q4 2020 Feb 08, 2021	BUY	$15.26 - $28.61 $453,099 - $849,488	29,692 New	29,692 $617,000

406

126M

3.29M

2.01M

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $4.95B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

Get notified when there are updates to the investment portfolio of Hc Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Hc Advisors, LLC with notifications on news.